Morgan Stanley analyst Sanjit Singh lowered the firm’s price target on UiPath (PATH) to $17 from $19 and keeps an Equal Weight rating on the shares. Sustained Q4 ARR growth and FY27 ARR guidance that implies generally flat NNARR suggests stability in a period of uncertainty for automation players, the analyst tells investors.
Claim 55% Off TipRanks
Trade PATH with leveragePublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH:
- UiPath price target lowered to $13 from $17 at UBS
- UiPath Delivers First Full-Year Profit and New Buyback
- Closing Bell Movers: Netscope down 17%, UiPath down 5% on earnings
- UiPath raises long-term operating margin target to 30% from above 20%
- PATH Earnings: UiPath’s Financial Results Top Wall Street Forecasts